Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00385086 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lumbar Spinal Fibrosis and TNF Alpha Inhibition

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Publications: details revised at 1 of 1 entry Collaborators expanded, about 5 wordsv6 Show all 2 changesShow less
    • Collaborators expanded, about 5 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study completion date changed from estimate of Jun 2013 to Dec 2014 Trial status: Active, Not Recruiting to Completed · Enrollment target: estimated 40 to confirmed 38v5 Show all 3 changesShow less
    • Trial status: Active, Not Recruiting to Completed
    • Enrollment target: estimated 40 to confirmed 38
  3. Primary completion date changed from estimate of Sep 2012 to Oct 2012 Completion date: Jan 2013 to Jun 2013v4 Show all 2 changesShow less
    • Completion date: Jan 2013 to Jun 2013
  4. Trial status: Recruiting to Active, Not Recruiting Primary completion date: Sep 2012 · Completion date: Nov 2008 to Jan 2013 · Interventions: TNF blocker (Drug) to Placebo (Drug), TNF blocker (Drug) · 3 morev3 Show all 7 changesShow less
    • Primary completion date: Sep 2012
    • Completion date: Nov 2008 to Jan 2013
    • Interventions: TNF blocker (Drug) to Placebo (Drug), TNF blocker (Drug)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Study arms: 0 to 2
  5. Trial status: Not Yet Recruiting to Recruiting Start date: Nov 2006 to Feb 2007 · Site details revisedv2 Show all 3 changesShow less
    • Start date: Nov 2006 to Feb 2007
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
TNF-alpha is the main cytokine implicated in the formation of lumbar spinal fibrosis. Inhibiting TNF-alpha could significantly decrease spinal fibrosis after lumbar discectomy.
Trial Details
NCT Number NCT00385086
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions Post Operative Sciatica by Lumbar Spinal Fibrosis
Enrollment 38 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov